The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

NCT01022333 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DIETARY_SUPPLEMENT: Diindolylmethane (DIM)

Sponsor

Women's College Hospital

Collaborators

[object Object]